Biogen Inc. (NASDAQ: BIIB) stock closed at 202.9 per share at the end of the most recent trading day (a 2.28% change compared to the prior day closing price) with a volume of 628.11K shares and market capitalization of 28.63B. Is a component of S&P 500, NASDAQ 100, Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 9100 people. Biogen Inc. CEO is Michel Vounatsos.

The one-year performance of Biogen Inc. stock is -27.8%, while year-to-date (YTD) performance is -15.43%. BIIB stock has a five-year performance of -19.74%. Its 52-week range is between 187.16 and 468.55, which gives BIIB stock a 52-week price range ratio of 2.97%

Biogen Inc. currently has a PE ratio of 20.40, a price-to-book (PB) ratio of 2.59, a price-to-sale (PS) ratio of 2.69, a price to cashflow ratio of 9.70, a PEG ratio of 2.32, a ROA of 6.28%, a ROC of 8.77% and a ROE of 13.59%. The company’s profit margin is 14.08%, its EBITDA margin is 25.20%, and its revenue ttm is $10.82 Billion , which makes it $73.88 revenue per share.

Of the last four earnings reports from Biogen Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $4.41 for the next earnings report. Biogen Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Biogen Inc. is Moderate Buy (2.09), with a target price of $271.18, which is +38.55% compared to the current price. The earnings rating for Biogen Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Biogen Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Biogen Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 10.35, ATR14 : 6.96, CCI20 : -30.96, Chaikin Money Flow : -0.24, MACD : -3.69, Money Flow Index : 43.65, ROC : -2.19, RSI : 49.13, STOCH (14,3) : 57.00, STOCH RSI : 1.00, UO : 51.32, Williams %R : -43.00), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Biogen Inc. in the last 12-months were: Alfred W. Sandrock (Sold 15 344 shares of value $6 751 360 ), Brian S. Posner (Sold 720 shares of value $197 402 ), Chirfi Guindo (Option Excercise at a value of $0), Chirfi Guindo (Sold 6 174 shares of value $2 716 560 ), Ginger Gregory (Option Excercise at a value of $0), Michael R. Mcdonnell (Option Excercise at a value of $2 031 130), Michel Vounatsos (Option Excercise at a value of $0), Nicole Murphy (Option Excercise at a value of $0), Rachid Izzar (Option Excercise at a value of $85 009), Robin C. Kramer (Option Excercise at a value of $175 158), Susan H. Alexander (Option Excercise at a value of $0)